Intramedullary Nails Market is segmented By Type (Long gamma nail (LGN), Trochanteric femoral nail (TFN), Intertroch/subtroch nail (ITST), Others), By Material (Titanium, Stainless Steel), By Application (Femoral Fracture, Tibial Fracture, Others), By End User (Hospitals & Ambulatory Surgical Clinics, Specialty/Orthopedic Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Market Overview
Intramedullary Nails Market is forecasted to reach at a CAGR of 6.5 % during the forecast period (2024-2031).
The intramedullary nail is a metal rod threaded into and through the crack of the medullary cavity of a bone to provide strong protection for the broken bone. For the treatment of femoral shaft fractures, intramedullary nailing is currently considered the gold standard. For most fractures, intramedullary fixation is useful and necessary. Nailing may be applied on proximal and distal extra-articular fractures for more modern nail styles and attention to technique. The growth of the global market for intramedullary nails is projected to rely primarily on the volume of operations undertaken to restore fractured bones. In addition, intramedullary nail fixation has emerged as the gold standard procedure for femoral shaft fractures, a trend predicted during the projected timeframe to fuel the global demand for intramedullary nails.
Market Summary
| Metrics | Details |
| Market CAGR | 6.5% |
| Segments Covered | By Type, By Material, By Application, By End-User, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
For More Insights Request Free Sample
Market Dynamics
Increasing geriatric population drives market growth
Older adults (65 and up) have a higher risk of injuries and are more vulnerable to damage from even slight force. As a result, older people are at a greater risk of catastrophic fracture through high- or low-impact processes. Four out of every ten women over the age of 50 will undergo a hip, vertebral, or forearm fracture during their lifespan and are more likely to die from fracture complications than breast cancer. A report released by the NCBI in 2020 revealed that between 2015 and 2025, there were about 347,564 hip fractures in Spain. Hip fractures impact more than 85% of people over the age of 65. Thus, the increase in the older population accelerates the market growth. Additionally, the market growth is expected to be fueled due to an increase in injury/sports accidents, an increase in the prevalence of degenerative bone diseases, and an increasing geriatric population. It is expected that technical developments in trauma fixation systems will expand the global demand in the near future.
However, the stringent government regulations for orthopedic implants coupled with the complications associated with the use of intramedullary nails is a key factor expected to curtail the growth of the global market over the forecast period.
Market Segmentation Analysis
The trochanteric femoral nail (TFN) segment is projected to be the dominant segment in the market during the forecast period.
Based on the type, the intramedullary nails market has been classified into long gamma nail (LGN), trochanteric femoral nail (TFN), intertroch/subtroch nail (ITST), and others.
Trochanteric femoral nails (TFN) dominated the global market in 2021, whereas the long gamma nail (LGN) is expected to present considerable growth in the near future. It is intended to treat stable and unstable proximal femur fractures, including basal neck fractures, intertrochanteric fractures, and pertrochanteric fractures and combinations. Therefore, the increasing usage of Trochanteric Femoral nails in the treatment is expected to propel segmental growth in the near future.
The global intramedullary nails are segmented on the basis of material, which includes titanium and stainless steel.
Titanium is expected to hold a significant market share in the intramedullary nails market. The added advantages of titanium, such as better biocompatibility and durability, support the segment growth during the forecast period. Moreover, titanium is expected to project a considerable CAGR during the forecast period.
Market Geographical Share
North America region is expected to dominate the global intramedullary nails market
Based on geography, the study analyzes the intramedullary nails market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
North America is holding a dominant position in the global intramedullary nails market in 2021. In North America, the U.S. is expected to represent considerable growth during the forecast period. Well-established healthcare infrastructure and high healthcare expenditure per capita in the country result in a huge market for intramedullary nails. Moreover, Europe is expected to represent significant growth in terms of value during the forecast period. The increasing number of injuries and road accidents is expected to propel market growth across the region.
The intramedullary nails market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the large population base, especially in India and China. Moreover, an increase in the incidence of orthopedic diseases and economic growth are expected to augment the growth of the Asia Pacific intramedullary nails market.
Market Companies
The key intramedullary nails market players which are contributing to the growth of the global market include Stryker, B. Braun Melsungen AG., Zimmer Biomet., Smith+Nephew., Johnson & Johnson., Orthopaedic Implant Company., Orthofix Holdings, Inc, Wright Medical Group N.V., Advanced Orthopaedic Solutions, Aysam Ortopedi & Tibbi Cihazlar, among others. The major players are adopting new Type launch and expansion strategies for global growth in the intramedullary nails market. In September 2022, Stryker launched New Gamma4 Hip Fracture Nailing System. This new Gamma System gave surgeons the next generation of Stryker’s intramedullary nailing system. This system is indicated for the treatment of stable and unstable fractures as well as for the stabilization of bones and correction of bone deformities in the intracapsular, trochanteric, subtrochanteric and shaft regions of the femur. This system is used in different features like precision pin, which reduce the potential of skiving by 66%. In September 2021, B.Braun Melsungen AG completed the acquisition of Sterinova Inc.
Furthermore, Sterinova continues to operate as a subsidiary of B.Braun. In March 2022, B.Braun acquired Intermedt Medizin & Technik GmbH, a specialist in preparing dialysis concentrates. Through this acquisition, the company completed the extensive product portfolio of its B. Braun Avitum division as a systems provider for extracorporeal blood treatment (dialysis).
COVID-19 Impact:
Stable growth of the global intramedullary nails market.
The growth of the global demand for intramedullary nails is projected to stay stable throughout the emergence of the COVID-19 pandemic, as non-COVID-related healthcare facilities continue to run at a regular pace. The market for intramedullary nails is expected to stay stable in the wake of the current COVID-19 pandemic. Surgeries and surgical treatments are listed as critical facilities worldwide. Market participants must solve the supply chain issues raised by the COVID-19 pandemic and design appropriate solutions to resolve them.
The global intramedullary nails market report would provide an access to approximately 69 market data tables, 61 figures and 170 pages
